» Articles » PMID: 27340384

Roles of IL-33 in Resistance and Tolerance to Systemic Candida Albicans Infections

Overview
Journal Immune Netw
Date 2016 Jun 25
PMID 27340384
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

IL-33 is a multifunctional cytokine that is released in response to a variety of intrinsic and extrinsic stimuli. The role of IL-33 in Candida albicans infections is just beginning to be revealed. This cytokine has beneficial effects on host defense against systemic C. albicans infections, and it promotes resistance mechanisms by which the immune system eliminates the invading fungal pathogens; and it also elevates host tolerance by reducing the inflammatory response and thereby, potentially, tissue damage. Thus, IL-33 is classified as a cytokine that has evolved functionally to protect the host from damage by pathogens and immunopathology.

Citing Articles

Dual function of fungi-derived cytokines in inflammatory bowel diseases: protection or inflammation.

Sharifinejad N, Mahmoudi E Gastroenterol Rep (Oxf). 2023; 11:goad068.

PMID: 38058517 PMC: 10697736. DOI: 10.1093/gastro/goad068.


Biomarkers for the severity of periodontal disease in patients with obstructive sleep apnea:IL-1 β, IL-6, IL-17A, and IL-33.

Tellez Corral M, Daza E, Jimenez N, Morales Vera D, Velosa Porras J, Uriza C Heliyon. 2023; 9(3):e14340.

PMID: 36967976 PMC: 10031375. DOI: 10.1016/j.heliyon.2023.e14340.


The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications.

Ryan N, Anderson K, Volpedo G, Varikuti S, Satoskar M, Satoskar S Front Cell Infect Microbiol. 2020; 10:153.

PMID: 32363166 PMC: 7180392. DOI: 10.3389/fcimb.2020.00153.

References
1.
Lionakis M . New insights into innate immune control of systemic candidiasis. Med Mycol. 2014; 52(6):555-64. PMC: 4823972. DOI: 10.1093/mmy/myu029. View

2.
Kim J, Kim W, Moon U, Kim H, Choi H, Sin J . Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth. J Immunol. 2016; 196(5):2410-23. DOI: 10.4049/jimmunol.1501730. View

3.
Le H, Kim W, Kim J, Cho H, Kwon B . Interleukin-33: a mediator of inflammation targeting hematopoietic stem and progenitor cells and their progenies. Front Immunol. 2013; 4:104. PMC: 3644799. DOI: 10.3389/fimmu.2013.00104. View

4.
Alves-Filho J, Sonego F, Souto F, Freitas A, Verri Jr W, Auxiliadora-Martins M . Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med. 2010; 16(6):708-12. DOI: 10.1038/nm.2156. View

5.
Molofsky A, Van Gool F, Liang H, Van Dyken S, Nussbaum J, Lee J . Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation. Immunity. 2015; 43(1):161-74. PMC: 4512852. DOI: 10.1016/j.immuni.2015.05.019. View